Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis in Patients on Palliative Treatment for Advanced Breast Cancer

    January 2023 in “ Figshare ”
    Mattea Reinisch, Norbert Marschner, Thorsten Otto, Agnieszka Korfel, C. Stoffregen, Achim Wöckel
    TLDR Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.
    The study aimed to understand the preferences of postmenopausal patients with advanced breast cancer (aBC) regarding treatment goals and side effects. Conducted in Germany, it involved 104 patients using an adaptive choice-based conjoint (ACBC) analysis. The results showed that quality of life (QoL), particularly "physical agility and mobility," was the most important factor for patients, followed by overall survival (OS) and progression-free survival (PFS). Side effects were less significant, with nausea/vomiting being the most concerning. The study concluded that QoL, OS, and PFS should be equally prioritized in treatment decisions for aBC.
    Discuss this study in the Community →